Using an in vitro translation assay to screen a human brain cDNA library, we isolated the microtubuleassociated protein Tau and determined it to be a caspase-3 substrate whose C-terminal cleavage occurred during neuronal apoptosis. ⌬Tau, the 50-kDa cleavage product, was detected by Western blot in apoptotic cortical cells probed with anti-PHF-1 and anti-Tau-5 antibodies, but not anti-T-46 antibody which recognizes the C-terminus. Overexpression of ⌬Tau in SK-N-BE2(C) cells significantly increased the incidence of cell death. Staurosporine-induced Tau cleavage was blocked by 20 M z-Asp-Glu-Val-Asp-chloromethylketone, a caspase-3 inhibitor, and in vitro, Tau was selectively cleaved by caspase-3 or calpain, a calcium-activated protease, but not by caspases-1, -8, or -9. (D421E)-Tau, a mutant in which Asp421 was replaced with a Glu, was resistant to cleavage by caspase-3 and tended to suppress staurosporine-induced cell death more efficiently than did wildtype Tau in both transient and stable expression systems. Finally, the incidence of ⌬Tau-induced cell death was augmented by expression of A␤ precursor protein (APP) or Swedish APP mutant. Taken together, these results suggest that the caspase-3 cleavage product of Tau may contribute to the progression of neuronal cell death in Alzheimer's disease.
INTRODUCTION
Apoptosis, or programmed cell death, is a genetically regulated, cellular suicide mechanism that controls development and homeostasis in multicellular organisms. Inappropriate onset or defects in sensitivity to an apoptotic stimulus can give rise to a number of clinical conditions, including neurodegenerative disorders, autoimmunity, and cancer (O'Reilly and Strasser, 1999; Tatton and Olanow, 1999; Zhivotovsky et al., 1999) . Caspases, a highly conserved family of cysteine proteases, play a critical role in programmed mammalian cell death (Yuan et al., 1993) , suggesting that caspase could potentially serve as a useful as therapeutic target for controlling inappropriate apoptosis (Thornberry et al., 1992; Deigner, 1999) . For example, caspase inhibitors prevent cell death induced by Fas (Enari et al., 1995) and neurotrophic factor deprivation (Gagliardini et al., 1994) , as well as the programmed death of motoneurons (Milligan et al., 1995) . In addition, caspase-3, -9, and -12 (Ϫ/Ϫ) mutant mice show decreased apoptosis, resulting in altered nervous system development (Kuida et al., 1996 (Kuida et al., , 1998 Hakem et al., 1998; Nakagawa et al., 2000) .
Caspases induce cell death by selective proteolysis of a subset of cellular proteins with specificity for aspartic acid residues in their substrates. To date, 14
